- Record: found
- Abstract: found
- Article: not found
Amniopatch as an active treatment of spontaneous previable rupture of membranes.
Vladimír Ferianec
1 ,
Marián Križko
1 ,
Martin Gábor
1 ,
Peter Papcun
1 ,
Martin Alföldi
1 ,
Michaela Feriancová
1
Dec 2022
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To assess the use of amniopatch - intraamniotic application of maternal platelets and cryoprecipitate, in patients after spontaneous previable rupture of membranes (sPPPROM) in terms of its effect on the course and outcome of pregnancy in the largest cohort so far. Since the amniopatch is currently used only to treat patients with iatrogenic preterm rupture of membranes, aim of this study was to find out, if amniopatch could be also used in case of sPPPROM as a safe alternative to currently used expectant management and to compare the results with published data on expectant management.